• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Policy entrepreneurs are integral in efforts to curb antimicrobial resistance in low and middle income countries.

作者信息

Otaigbe Idemudia Imonikhe

机构信息

Department of Medical Microbiology, School of Basic Clinical Sciences, Benjamin Carson (Snr) College of Health and Medical Sciences, Babcock University/Babcock University Teaching Hospital, Ilishan Remo, Ogun State, Nigeria.

出版信息

Front Public Health. 2024 Mar 12;12:1292660. doi: 10.3389/fpubh.2024.1292660. eCollection 2024.

DOI:10.3389/fpubh.2024.1292660
PMID:38532974
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10963478/
Abstract
摘要

相似文献

1
Policy entrepreneurs are integral in efforts to curb antimicrobial resistance in low and middle income countries.政策企业家在中低收入国家遏制抗菌药物耐药性的努力中不可或缺。
Front Public Health. 2024 Mar 12;12:1292660. doi: 10.3389/fpubh.2024.1292660. eCollection 2024.
2
Surveillance of antimicrobial resistance in low- and middle-income countries: a scattered picture.中低收入国家抗菌药物耐药性监测：支离破碎的图景。
Antimicrob Resist Infect Control. 2021 Mar 31;10(1):63. doi: 10.1186/s13756-021-00931-w.
3
Antimicrobial resistance in low- and middle-income countries: current status and future directions.中低收入国家的抗微生物药物耐药性：现状和未来方向。
Expert Rev Anti Infect Ther. 2022 Feb;20(2):147-160. doi: 10.1080/14787210.2021.1951705. Epub 2021 Jul 19.
4
Using 'smart regulation' to tackle antimicrobial resistance in low-income and middle-income countries.利用“智能监管”应对低收入和中等收入国家的抗菌药物耐药性问题。
BMJ Glob Health. 2020 Jan 30;5(1):e001864. doi: 10.1136/bmjgh-2019-001864. eCollection 2020.
5
Closing the GAP in Antimicrobial Resistance Policy in Benin and Burkina Faso.终结贝宁和布基纳法索抗菌药物耐药性政策差距。
mSystems. 2022 Aug 30;7(4):e0015022. doi: 10.1128/msystems.00150-22. Epub 2022 Jul 27.
6
Research, Innovation, and Policy: An Alliance Combating Antimicrobial Resistance.研究、创新与政策：抗击抗微生物药物耐药性联盟
Trends Microbiol. 2019 Apr;27(4):287-289. doi: 10.1016/j.tim.2018.12.005. Epub 2019 Jan 9.
7
Use of Social Media as a Tool to Reduce Antibiotic Usage: A Neglected Approach to Combat Antimicrobial Resistance in Low and Middle Income Countries.利用社交媒体作为减少抗生素使用的工具：一种在低收入和中等收入国家对抗抗菌药物耐药性的被忽视的方法。
Front Public Health. 2020 Dec 10;8:558576. doi: 10.3389/fpubh.2020.558576. eCollection 2020.
8
The Structured Operational Research and Training Initiative for Strengthening Health Systems to Tackle Antimicrobial Resistance and Improve Public Health in Low-and-Middle Income Countries.强化卫生系统以应对抗微生物药物耐药性并改善中低收入国家公共卫生的结构性操作性研究和培训倡议。
Int J Environ Res Public Health. 2022 Apr 11;19(8):4582. doi: 10.3390/ijerph19084582.
9
What's wrong in the control of antimicrobial resistance in critically ill patients from low- and middle-income countries?低收入和中等收入国家重症患者抗菌药物耐药性控制存在哪些问题？
Intensive Care Med. 2018 Jan;44(1):79-82. doi: 10.1007/s00134-017-4795-z. Epub 2017 Apr 13.
10
Antimicrobial Resistance in Low- and Middle-income Countries.低收入和中等收入国家的抗菌药物耐药性
Clin Infect Dis. 2019 Sep 13;69(7):1264-1265. doi: 10.1093/cid/ciz127.

本文引用的文献

1
Achieving universal health coverage in low- and middle-income countries through digital antimicrobial stewardship.通过数字抗菌药物管理在低收入和中等收入国家实现全民健康覆盖。
Front Digit Health. 2023 Dec 15;5:1298861. doi: 10.3389/fdgth.2023.1298861. eCollection 2023.
2
Drivers of inappropriate antibiotic use in low- and middle-income countries.低收入和中等收入国家不适当使用抗生素的驱动因素。
JAC Antimicrob Resist. 2023 May 31;5(3):dlad062. doi: 10.1093/jacamr/dlad062. eCollection 2023 Jun.
3
Antimicrobial Resistance Policy Protagonists and Processes-A Qualitative Study of Policy Advocacy and Implementation.抗菌药物耐药性政策倡导者与流程——一项关于政策倡导与实施的定性研究
Antibiotics (Basel). 2022 Oct 18;11(10):1434. doi: 10.3390/antibiotics11101434.
4
Extending political will into action in African LMICs: abating global antimicrobial resistance.将政治意愿转化为非洲低收入和中等收入国家的实际行动：减轻全球抗菌药物耐药性
Lancet Microbe. 2022 May;3(5):e327-e328. doi: 10.1016/S2666-5247(22)00063-5. Epub 2022 Mar 22.
5
Surveillance of antimicrobial resistance in low- and middle-income countries: a scattered picture.中低收入国家抗菌药物耐药性监测：支离破碎的图景。
Antimicrob Resist Infect Control. 2021 Mar 31;10(1):63. doi: 10.1186/s13756-021-00931-w.
6
Policy actors and human and animal health practitioners' perceptions of antimicrobial use and resistance in Tanzania: A qualitative study.坦桑尼亚政策制定者以及人类和动物健康从业者对抗菌药物使用及耐药性的认知：一项定性研究
J Glob Antimicrob Resist. 2021 Jun;25:40-47. doi: 10.1016/j.jgar.2021.02.027. Epub 2021 Mar 1.
7
A road-map for addressing antimicrobial resistance in low- and middle-income countries: lessons learnt from the public private participation and co-designed antimicrobial stewardship programme in the State of Kerala, India.解决中低收入国家抗菌药物耐药问题的路线图：从印度喀拉拉邦公私参与和共同设计的抗菌药物管理方案中吸取的经验教训。
Antimicrob Resist Infect Control. 2021 Feb 11;10(1):32. doi: 10.1186/s13756-020-00873-9.
8
Antimicrobial resistance control efforts in Africa: a survey of the role of Civil Society Organisations.非洲的抗菌药物耐药性控制工作：民间社会组织作用的调查。
Glob Health Action. 2021 Jan 1;14(1):1868055. doi: 10.1080/16549716.2020.1868055.
9
The Role of the Private Sector in Advancing Antimicrobial Stewardship: Recommendations from the Global Chief Medical Officers' Network.私营部门在推进抗菌药物管理中的作用：全球首席医疗官网络的建议。
Popul Health Manag. 2021 Apr;24(2):231-240. doi: 10.1089/pop.2020.0027. Epub 2020 Jul 13.
10
Antimicrobial Resistance Surveillance in Low- and Middle-Income Countries: Progress and Challenges in Eight South Asian and Southeast Asian Countries.中低收入国家的抗微生物药物耐药性监测：八个南亚和东南亚国家的进展和挑战。
Clin Microbiol Rev. 2020 Jun 10;33(3). doi: 10.1128/CMR.00048-19. Print 2020 Sep 16.